DK166677B1 - Analogifremgangsmaade til fremstilling af substituerede 3,4-diamino-1,2,5-thiadiazoler - Google Patents

Analogifremgangsmaade til fremstilling af substituerede 3,4-diamino-1,2,5-thiadiazoler Download PDF

Info

Publication number
DK166677B1
DK166677B1 DK141383A DK141383A DK166677B1 DK 166677 B1 DK166677 B1 DK 166677B1 DK 141383 A DK141383 A DK 141383A DK 141383 A DK141383 A DK 141383A DK 166677 B1 DK166677 B1 DK 166677B1
Authority
DK
Denmark
Prior art keywords
amino
thiadiazole
toxic
pharmaceutically acceptable
hydrate
Prior art date
Application number
DK141383A
Other languages
Danish (da)
English (en)
Other versions
DK141383D0 (da
DK141383A (da
Inventor
Ronnie Ray Crenshaw
Aldo Antonio Algieri
Original Assignee
Squibb Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb Bristol Myers Co filed Critical Squibb Bristol Myers Co
Publication of DK141383D0 publication Critical patent/DK141383D0/da
Publication of DK141383A publication Critical patent/DK141383A/da
Application granted granted Critical
Publication of DK166677B1 publication Critical patent/DK166677B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/06—1,2,3-Thiadiazoles; Hydrogenated 1,2,3-thiadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK141383A 1982-03-29 1983-03-28 Analogifremgangsmaade til fremstilling af substituerede 3,4-diamino-1,2,5-thiadiazoler DK166677B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36320782A 1982-03-29 1982-03-29
US36320782 1982-03-29

Publications (3)

Publication Number Publication Date
DK141383D0 DK141383D0 (da) 1983-03-28
DK141383A DK141383A (da) 1983-09-30
DK166677B1 true DK166677B1 (da) 1993-06-28

Family

ID=23429274

Family Applications (2)

Application Number Title Priority Date Filing Date
DK141383A DK166677B1 (da) 1982-03-29 1983-03-28 Analogifremgangsmaade til fremstilling af substituerede 3,4-diamino-1,2,5-thiadiazoler
DK081192A DK81192A (da) 1982-03-29 1992-06-18 Substituerede ethandiimidamider og fremgangsmaade til fremstilling deraf

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK081192A DK81192A (da) 1982-03-29 1992-06-18 Substituerede ethandiimidamider og fremgangsmaade til fremstilling deraf

Country Status (30)

Country Link
JP (2) JPS58180477A (ko)
KR (1) KR880002209B1 (ko)
AT (1) AT386599B (ko)
AU (2) AU557577B2 (ko)
BE (1) BE896291A (ko)
CH (2) CH660880A5 (ko)
CS (2) CS250240B2 (ko)
DD (2) DD219768A5 (ko)
DE (1) DE3311281A1 (ko)
DK (2) DK166677B1 (ko)
ES (3) ES520982A0 (ko)
FR (2) FR2542741B1 (ko)
GB (2) GB2117769B (ko)
GR (1) GR78524B (ko)
HU (2) HU196386B (ko)
IE (1) IE55596B1 (ko)
IL (1) IL68259A0 (ko)
IT (1) IT1164633B (ko)
LU (1) LU84716A1 (ko)
MY (1) MY8700942A (ko)
NL (1) NL8301063A (ko)
NO (1) NO163055C (ko)
NZ (1) NZ203726A (ko)
OA (1) OA07356A (ko)
PT (1) PT76459B (ko)
SE (2) SE461040B (ko)
SU (2) SU1419518A3 (ko)
YU (1) YU44849B (ko)
ZA (1) ZA832154B (ko)
ZW (1) ZW7683A1 (ko)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2222083A (en) * 1982-12-14 1984-06-21 Smith Kline & French Laboratories Limited Pyridine derivatives
US4593039A (en) * 1984-04-02 1986-06-03 Merck & Co., Inc. 1-aryloxy-3-(substituted aminoalkylamino)-2-propanols
US4644006A (en) * 1984-06-22 1987-02-17 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
JPH0622828B2 (ja) * 1986-06-30 1994-03-30 フアナツク株式会社 直圧式型締機構
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3018289A (en) * 1960-02-10 1962-01-23 Wyandotte Chemicals Corp Process for preparing oxamidines
GB1595291A (en) * 1976-09-21 1981-08-12 Smith Kline French Lab Pyrimidone and thiopyrimidone derivatives
NL189197C (nl) * 1979-09-04 1993-02-01 Bristol Myers Squibb Co 3,4-digesubstitueerde-1,2,5-thiadiazool-1-oxiden en 1,1-dioxiden, bereiding daarvan alsmede farmaceutische preparaten.
DE3175201D1 (en) * 1980-04-30 1986-10-02 Merck & Co Inc Aminothiadiazoles as gastric secretion inhibitors
AU2222083A (en) * 1982-12-14 1984-06-21 Smith Kline & French Laboratories Limited Pyridine derivatives

Also Published As

Publication number Publication date
GB2117769A (en) 1983-10-19
OA07356A (fr) 1984-08-31
ES8404683A1 (es) 1984-05-16
MY8700942A (en) 1987-12-31
ES8505978A1 (es) 1985-06-16
FR2597867A1 (fr) 1987-10-30
NO163055B (no) 1989-12-18
SE8704689L (sv) 1987-11-25
DE3311281A1 (de) 1983-11-24
NL8301063A (nl) 1983-10-17
FR2597867B1 (fr) 1989-12-08
FR2542741A1 (fr) 1984-09-21
DD219768A5 (de) 1985-03-13
IE830686L (en) 1983-09-29
GR78524B (ko) 1984-09-27
NZ203726A (en) 1986-05-09
ZA832154B (en) 1983-12-28
ES8505977A1 (es) 1985-06-16
SU1355123A3 (ru) 1987-11-23
DD210909A5 (de) 1984-06-27
DK141383D0 (da) 1983-03-28
ATA111083A (de) 1988-02-15
DK81192D0 (da) 1992-06-18
AU6327286A (en) 1987-01-08
SU1419518A3 (ru) 1988-08-23
AU586037B2 (en) 1989-06-29
GB2149406B (en) 1986-01-02
PT76459B (en) 1986-03-11
AU1290783A (en) 1983-10-06
DK81192A (da) 1992-06-18
SE8301725D0 (sv) 1983-03-28
JPS58180477A (ja) 1983-10-21
IE55596B1 (en) 1990-11-21
IT8348005A0 (it) 1983-03-28
GB2149406A (en) 1985-06-12
HU196386B (en) 1988-11-28
YU74483A (en) 1986-02-28
YU44849B (en) 1991-04-30
AT386599B (de) 1988-09-12
CS250229B2 (en) 1987-04-16
IL68259A0 (en) 1983-06-15
GB8308518D0 (en) 1983-05-05
KR880002209B1 (ko) 1988-10-18
AU557577B2 (en) 1986-12-24
JPH0568472B2 (ko) 1993-09-29
SE461040B (sv) 1989-12-18
HU188742B (en) 1986-05-28
CH655111A5 (de) 1986-03-27
GB2117769B (en) 1985-08-29
SE464302B (sv) 1991-04-08
PT76459A (en) 1983-04-01
JPH06135925A (ja) 1994-05-17
ES527685A0 (es) 1985-06-16
FR2542741B1 (fr) 1989-12-08
IT1164633B (it) 1987-04-15
DK141383A (da) 1983-09-30
LU84716A1 (fr) 1983-12-05
ES520982A0 (es) 1984-05-16
KR840004095A (ko) 1984-10-06
CS250240B2 (en) 1987-04-16
ES527686A0 (es) 1985-06-16
NO163055C (no) 1990-03-28
NO831100L (no) 1983-09-30
ZW7683A1 (en) 1984-01-04
BE896291A (fr) 1983-09-28
GB8432809D0 (en) 1985-02-06
SE8704689D0 (sv) 1987-11-25
CH660880A5 (de) 1987-05-29
SE8301725L (sv) 1983-11-25

Similar Documents

Publication Publication Date Title
FI78695B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 1,2-diaminocyklobuten-3,4-dionderivat.
KR860002036B1 (ko) 히스타민 h₂-길항제의 제조방법
KR840001074B1 (ko) 티아줄 유도체의 제조방법
DK166677B1 (da) Analogifremgangsmaade til fremstilling af substituerede 3,4-diamino-1,2,5-thiadiazoler
FI69069C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara n-yan-n'-(2-((4-metyl-5-imidazolyl)metyltio)etyl)-n"-alkyny lganidiner
US4528377A (en) Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
US4528378A (en) Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
US4600779A (en) Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
DK170047B1 (da) Med basiske heterocycliske grupper substituerede 5-halogen-thienoisothiazol-3(2H)-on-1,1-dioxider og salte deraf, fremgangsmåde til fremstilling af sådanne forbindelser, farmaceutiske præparater indeholdende disse forbindelser og forbindelsernes anvendelse ved fremstilling af lægemidler til behandling af angsttilstande
DK167679B1 (da) Substituerede isoxazol-derivater, en fremgangsmaade til fremstilling deraf og farmaceutiske praeparater indeholdende saadanne derivater
US4588826A (en) Ethanediimidamide intermediates
US4578471A (en) Substituted amino alkyl pyridyl ethanediimidamides
KR880002530B1 (ko) 치환된 에탄디이미드 아미드 및 그의 제조방법
NO880872L (no) Fremgangsmaate til fremstilling av en kjemisk forbindelse.
US4595758A (en) Ethanediimidamide intermediates
US4517366A (en) Intermediates for preparing 3,4-diamino-1,2,5-thiadiazoles
KR900004321B1 (ko) 히스타민 h_2-섭수체 길항작용을 가진 치환 3,4-디아미노-1,2,5-티아디아졸류 및 그 제조방법
CA1253144A (en) Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine h.sub.2-receptor antagonist activity
NO154091B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenylaminoimidazolin-derivater.
NO157576B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktivt tioalkylamid av nikotinsyre-1-oksyd.
CS246052B2 (en) Method of 3,4-disubstituted 1,2,5-thiadiazole-1-oxides and-1,1-dioxides production

Legal Events

Date Code Title Description
PBP Patent lapsed